TRORILUZOLE is a third-generation tripeptide prodrug of the benzothiazole derivative riluzole, primarily utilized in neurological research as a glutamate modulator. This compound functions by increasing… Read more
TRORILUZOLE is a third-generation tripeptide prodrug of the benzothiazole derivative riluzole, primarily utilized in neurological research as a glutamate modulator. This compound functions by increasing the uptake of glutamate, a major excitatory neurotransmitter, to address glutamate dysregulation implicated in various neurodegenerative and psychiatric conditions, such as spinocerebellar ataxia and obsessive-compulsive disorder. The TRORILUZOLE category includes high-quality reference standards, specific impurities, metabolites, and stable isotope labelled versions essential for rigorous pharmaceutical analysis. These materials are critical for researchers and quality control laboratories performing precise impurity profiling, method validation, and accurate quantification during the development and stability testing of drug formulations. By providing consistent, reliable standards, these products support the investigation of this glutamate-modulating agent and ensure the integrity of analytical workflows throughout the drug development process.